GuillaumeMonnier

Associate

Paris + 33.1.56.59.39.40

Connect

Share

Guillaume Monnier advises issuers and underwriters in debt and equity capital markets transactions as well as public M&A transactions. His experience includes initial public offerings (IPOs), rights issues/capital increases, block trades, convertible and exchangeable bonds, stand-alone issues, debt securities under euro medium-term note (EMTN) programmes, and liability management. Furthermore, Guillaume regularly advises companies listed in France on their periodic and ongoing disclosure requirements.

Since joining Jones Day in 2020, Guillaume has advised issuers and bank syndicates on capital market transactions involving Alchimie, Forsee Power, Lhyfe, Spartoo, and Waga Energy (IPOs); DEE Tech (SPAC/special purpose acquisition company); Compagnie des Alpes, Carbios, EDAP TMS, Forsee Power, MedinCell, OSE Immunotherapeutics, Valneva, and Waga Energy (rights issues/capital increases); Bombardier and SC de l'Ermitage Saint Joseph (block trades); Bigben Interactive and Voltalia (convertible/exchangeable bonds); EDF (liability management); Sanofi/Opella Healthcare (public M&A); and H2O Innovation (delisting).

Prior to joining Jones Day, Guillaume practiced at an international law firm in Paris.

Erfahrung

  • Sanofi to separate its consumer healthcare business, OpellaJones Day is acting as securities law counsel to Sanofi in the separation of Opella, its consumer healthcare business, and the announced sale of a 50% controlling stake.
  • Valneva raises €61 million in accelerated bookbuilding offeringJones Day advised Valneva SE, a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs, in connection with its capital €61 million private placement through an accelerated bookbuilding process.
  • Waga Energy raises €52 million in accelerated bookbuilding offeringJones Day advised Waga Energy, an independent producer of renewable biomethane (RNG) from landfill gas with operations in Europe and North America, on its €52 million accelerated bookbuilding private placement.
  • H20 Innovation delists its shares on Euronext Growth in ParisJones Day acted as French counsel to H20 Innovation Inc., a Canadian company listed on the Toronto Stock Exchange and on the multilateral trading facility of Euronext Growth in Paris, in connection with the delisting of its shares trading on Euronext Growth in Paris.
  • Forsee Power completes €50 million capital increaseJones Day advised Forsee Power, a French company listed on the regulated market of Euronext Paris which specializes in the design, manufacture, and marketing of intelligent battery systems for the electromobility market, in its capital increase without shareholders’ preferential subscription rights but with priority subscription period for an amount of approximately €50 million.
  • EDAP completes follow-on public offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on public offering of 3,066,667 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Voltalia issues additional green bondsJones Day advised Voltalia in its offering of additional green bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs Vertes) due 2025 (the “New Bonds”) for a nominal amount of approximately €50 million (the “Offering”) fully fungible with the OCEANEs Vertes issued in January 2021 for a total nominal amount of approximately €200 million due on January 13, 2025, (the “Existing Bonds”).
  • Bank of America Europe acts as presenting bank of Volkswagen Group, Attestor Limited and Pon Holdings BV’s tender offer for and acquisition of Europcar MobilityJones Day advised Bank of America Europe acting as presenting bank in the €2.6 billion tender offer for and acquisition of Europcar Mobility Group launched by a consortium comprised of Volkswagen Group, Attestor Limited and Pon Holdings BV.
  • Bryan Garnier & Co Limited, Natixis, and Portzamparc complete up to €124 million IPO of Lhyfe on EuronextJones Day represented Bryan Garnier & Co Limited, Natixis, and Portzamparc (BNP Paribas Group), as joint lead managers and joint bookrunners, in connection with the up to €124 million initial public offering of Lhyfe on the regulated market of Euronext in Paris.
  • Forsee Power completes €115 million offering and IPO on regulated market of Euronext in ParisJones Day advised Forsee Power in connection with its initial public offering on the regulated market of Euronext in Paris and an offering of up to €115 million.
  • Waga Energy completes €110 million IPO on Euronext in Paris, with green shoe optionJones Day advised Waga Energy, a French company specialized in the recovery of landfill gas as biomethane, in connection with its €110 million initial public offering of Ordinary Shares on the regulated market of Euronext in Paris with an over-allotment option up to €123 million.
  • Natixis and TP ICAP Europe underwrite €31.4 million IPO of SpartooJones Day represented Natixis and TP ICAP Europe as joint global coordinators and joint bookrunners in connection with the €31.4 million initial public offering of Spartoo on Euronext Growth Paris.
  • Underwriters complete €231 million capital increase of Compagnie des AlpesJones Day represented a group of syndicate members in connection with the €231 million capital increase of Compagnie des Alpes, a leader in the leisure industry.
  • Deutsche Bank and Société Générale underwrite €165 million SPAC IPO by DEE TechJones Day represented Deutsche Bank, as sole global coordinator and joint bookrunner, and Société Générale, as joint bookrunner, in connection with the €165 million initial public offering by DEE Tech, the first ever French SPAC in the tech sector, which will be listed on the Professional Segment of the regulated market of Euronext Paris.
  • Underwriters complete €114 million capital increase of CarbiosJones Day represented the underwriters in connection with a capital increase of Carbios, a green chemistry company, of €114 million.
  • Bombardier sells entire stake in Alstom for €506 millionJones Day acted as French corporate and capital markets counsel to Bombardier Inc., a leading manufacturer of business jets, in the sale of its entire stake in Alstom S.A. for an amount of €506 million in an accelerated bookbuilt offering to qualified investors.
  • EDAP completes follow-on offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on offering of 4,150,000 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Berenberg, BNP Paribas, and TP ICAP Europe complete €87.3 million offering by Bigben Interactive of its inaugural senior conditionally secured bonds exchangeable into existing ordinary shares of NaconJones Day advised Berenberg, BNP Paribas, and TP ICAP Europe, as joint global coordinators and joint bookrunners, in connection with a €87.3 million offering by Bigben Interactive, a European player in video game development and publishing, in design and distribution of smartphone and gaming accessories as well as in audio products, of its inaugural senior conditionally secured bonds exchangeable into existing ordinary shares of Nacon due 2026.
  • SC de l’Ermitage Saint Joseph sells its interest in Pharmagest InteractiveJones Day represented SC de l’Ermitage Saint Joseph, a French société civile held by the founder and Chairman of the Board of Directors of Pharmagest, in the €73.6 million sale of all its shares in Pharmagest Interactive.
  • Bryan, Garnier & Co Limited and ODDO BHF SCA complete €29.8 million capital increase of MedinCell S.A.Jones Day represented Bryan, Garnier & Co Limited (acting via Bryan Garnier Securities SAS) and ODDO BHF SCA, as joint global coordinators and joint bookrunners, in connection with the €29.8 million capital increase of MedinCell S.A., a clinical stage pharmaceutical company.
    •

    Bitte beachten Sie vor dem Versenden:

    Die Informationen auf unserer Website sind für den allgemeinen Gebrauch und stellen keine Rechtsberatung dar. Der Versand dieser E-Mail ist nicht dazu bestimmt, ein Mandatsverhältnis zu begründen, und der Erhalt dieser E-Mail stellt kein Mandatsverhältnis dar. Alles, was Sie an jemanden in unserer Kanzlei senden, ist nicht vertraulich oder privilegiert, es sei denn, wir haben zugestimmt, Sie zu vertreten. Wenn Sie diese E-Mail versenden, bestätigen Sie, dass Sie diesen Hinweis gelesen und verstanden haben.